NEW YORK, NY, (NAMC) – Biomedical device company Arbios Systems, Inc.(OTCBB: ABOS) has completed a $1.35 million private placement. The placement was a combination of common stock and warrants.

Each unit purchased by an accredited investors gave them one common share and one warrant to purchase one half of a common share.

Under terms of the agreement, the Units were sold at a price of $1.10 per unit, and the warrants will be exercisable for a period of five years at a price of $1.50 per share. Participating in the financing were current investors, including several funds managed by LibertyView Capital Management (a division of Neuberger Berman, LLC, a Lehman Brothers company) as well as Bristol Investment Fund, Ltd. (advised by Bristol Capital Advisors, LLC), and a new, individual investor.

Arbios closed at $1.15 on Monday

J.C. Arens
Business News Correspondent
NAMC Newswire
www.namcnewswire.com

This article can be republished either online or in print as long as credit is given to the author and the NAMC Newswire.
 
NAMC Newswire articles can now be listened to on StreetIQ.com
http://www.streetiq.com/dir/NAMC.shtml#

To keep up to date with companies that we report on just register to receive the FREE Wall Street to Main Street Daily Newsletter. We feature companies that trade on the NYSE, AMEX, NASDAQ, OTCBB and Overseas, Keeping our readers informed daily. Just go to our site and register, it’s simple and free, www.namcnewswire.com/newsletter . Also be sure to visit the NAMC radio at www.namcnewswire.com/namcradio for the latest reports, interviews and corporate updates featured on the NAMC Newswire.